Skip to the content
BATM signs multi-year contract with CityFibre for Edgility
Collaboration with BIOASTER to develop molecular diagnostic tests
Directorate Changes
BATM Interim results 2022
Appointment of CEO of ADOR Diagnostics
BATM partners with CityFibre for Edgility
Block listing six monthly return
ANNUAL FINANCIAL REPORT - DTR 6.3.5 Disclosure
Appointment of Non-Executive Director
Transaction in own shares and Total Voting Rights
All posts
Categories